Where to Buy Tirzepatide in 2026: Verified US Provider List

Tirzepatide is sold in the United States under two brand names — Zepbound (FDA-approved for chronic weight management)^[1] and Mounjaro (FDA-approved for type 2 diabetes only)^[2]. It is also still legally available as a 503A compounded injectable through telehealth platforms, even though the FDA declared the tirzepatide shortage resolved in December 2024^[5]. This article walks through every legitimate US channel a patient can use to buy tirzepatide in 2026, with verified pricing from FDA labels, the LillyDirect patient site, and our live 80-provider compounded pricing dataset.

The four legal ways to buy tirzepatide in 2026

There are exactly four legitimate channels. Anything outside these — research peptides, gray-market vials shipped from overseas, sellers operating without a prescription — is either illegal, unsafe, or both. Stick to one of the following.

1. Brand Zepbound via LillyDirect single-dose vials (the cheapest brand path)^[3][4]

• What it is: Eli Lilly's own self-pay pharmacy channel selling Zepbound as single-dose vials (rather than the autoinjector pen). Launched in August 2024 to give cash-paying patients a dramatically cheaper brand-name option during and after the tirzepatide shortage. Lilly significantly reduced LillyDirect vial pricing on December 1, 2025, and introduced an additional discount program on February 23, 2026.
• How to get it: Get a Zepbound prescription from any licensed US prescriber. LillyDirect does not write the prescription itself — you bring your own prescriber, then fill the prescription through LillyDirect Pharmacy.
• Cash price (as of April 2026, post-Dec 1, 2025 reduction):
  • 2.5 mg: $299/month
  • 5 mg: $399/month
  • 7.5 mg: $499/month
  • 10 mg: $699/month
  • 12.5 mg: $699/month
  • 15 mg: $699/month
• Lilly Self Pay Journey Program (effective Feb 23, 2026): Eligible self-pay patients on the 7.5 mg, 10 mg, 12.5 mg, and 15 mg doses can access these higher tiers at $449/month through Lilly's Self Pay Journey Program, a significant discount versus the standard $499-$699 vial pricing. Eligibility is determined at the point of purchase on LillyDirect.
• Format: Single-dose vials, drawn up with a syringe. This is a different physical product from the autoinjector pen most patients picture when they think of Zepbound, even though the active ingredient and labeled dose are the same.
• Eligibility: Cash-paying US patients only. Patients with insurance that covers Zepbound are routed to the standard pharmacy benefit instead.
• Shipping: Direct to patient, all 50 states.
• Pricing as of April 2026 — always verify current pricing directly against pricinginfo.lilly.com/zepbound and LillyDirect before purchase. Lilly has changed these tiers multiple times in the past 18 months.

2. Brand Zepbound autoinjector pen via retail pharmacy^[1]

• What it is: The standard Zepbound autoinjector pen, filled at a normal retail pharmacy (CVS, Walgreens, Walmart, Costco, grocery store pharmacies, Amazon Pharmacy) and run through your commercial insurance.
• How to get it: See your PCP or a telehealth clinician. Zepbound is FDA-approved for patients with BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea).
• Cash price without insurance: Roughly $1,000-$1,300/month for the pen at the major retail pharmacies, depending on dose. The LillyDirect single-dose vial channel (above) is dramatically cheaper for cash-paying patients.
• Insured copay: Highly variable. With a covered formulary plan plus the Lilly savings card, commercially insured patients can sometimes pay as little as $25/month. Without coverage, the savings card alone caps the cash-equivalent price at a higher tier.

3. Brand Mounjaro via retail pharmacy (diabetes only)^[2]

• What it is: The same active ingredient (tirzepatide) sold under a different brand name and FDA-approved only for type 2 diabetes. Mounjaro is not FDA-approved for weight loss; using it for weight loss is off-label.
• How to get it: Requires a documented type 2 diabetes diagnosis to get insurance coverage. A clinician can prescribe it off-label for weight loss, but most commercial insurers will not cover Mounjaro without the diabetes diagnosis.
• Cash price without insurance: Roughly the same as Zepbound at retail — $1,000-$1,300/month for the pen.
• When this matters: If you have type 2 diabetes, Mounjaro is the on-label tirzepatide product and is more likely to be covered by your insurance than Zepbound. If you do not have type 2 diabetes, Zepbound is the correct product.

4. Compounded tirzepatide via 503A telehealth pharmacy^[6]

• What it is: A compounded preparation of tirzepatide prepared by a state-licensed 503A compounding pharmacy on a patient-specific prescription. This is the channel that dominated the telehealth market during the 2022-2024 tirzepatide shortage.
• Legal status in 2026: The FDA declared the tirzepatide shortage resolved on December 19, 2024^[5]. The FDA gave 503B outsourcing facilities until March 19, 2025 to wind down bulk-compounding of tirzepatide; since that date, 503B facilities can no longer mass-compound tirzepatide. 503A pharmacies can still compound tirzepatide for an individual patient when a prescriber documents a clinical need (e.g., a different dose, an allergy to an excipient, a non-commercial formulation). Most telehealth platforms continue to operate through this 503A pathway.
• Cash price: Typically $149-$349/month across the 80+ telehealth providers in our dataset, depending on the provider, the dose, and any first-month promotional pricing. Our GLP-1 Compounded Pricing Index tracks the median, 10th percentile, and 90th percentile prices live as our dataset updates.
• How to verify a provider: Look for PCAB accreditation, state board of pharmacy licensure in your state, and a real US-based clinician consult. See our PCAB accreditation investigation for the full vetting framework.
• What to avoid: Any seller offering tirzepatide without a prescription, any product shipped from outside the US, anything sold as "research peptide" or "not for human use," and any pharmacy that cannot show you a state license.

Which channel is cheapest?

Like semaglutide, the cheapest path depends on your insurance status and which form of tirzepatide you are willing to take. Here is the rough hierarchy in 2026:

1. Insurance + Lilly savings card — often $25/month if your plan covers Zepbound and you qualify for the manufacturer copay card. This is the cheapest path when it works.
2. Compounded tirzepatide via 503A telehealth — $149-$349/month with no insurance required. The cheapest path for cash-pay patients, but you are getting a compounded preparation, not the brand-name FDA-approved product.
3. LillyDirect single-dose Zepbound vials — $299/month (2.5 mg), $399 (5 mg), $499 (7.5 mg), and $699/month for the 10 mg, 12.5 mg, and 15 mg tiers as of April 2026. Eligible self-pay patients on 7.5 mg and above can access the Lilly Self Pay Journey Program at $449/month. The cheapest path to brand-name tirzepatide for cash-pay patients.
4. Retail pharmacy cash pay (pen) — $1,000-$1,300/month. Generally the most expensive option and rarely the right choice when LillyDirect single-dose vials exist.

For a side-by-side cost comparison across the entire provider universe, see our cheapest tirzepatide providers listicle. For the full ranked directory of every telehealth platform offering tirzepatide, see best tirzepatide providers.

Zepbound vs Mounjaro: which one do you actually want?

Zepbound and Mounjaro are the same molecule (tirzepatide) in the same delivery format (autoinjector pen), at the same labeled doses (2.5, 5, 7.5, 10, 12.5, and 15 mg). They are manufactured by the same company (Eli Lilly) on the same production lines. The difference is the FDA label:

• Zepbound — FDA-approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related comorbidity. Also FDA-approved for moderate to severe obstructive sleep apnea in adults with obesity. This is the correct product if your indication is weight loss.
• Mounjaro — FDA-approved only for type 2 diabetes as an adjunct to diet and exercise. Not approved for weight loss. If you have type 2 diabetes, Mounjaro is the on-label product and is more likely to be covered by your insurance.

For a deeper comparison of both brands plus a head-to-head with Wegovy, see our Foundayo vs Wegovy vs Zepbound comparison.

How the dispensing chain actually works

Tirzepatide reaches a US patient through one of three distinct supply chains:

• Brand Zepbound or Mounjaro — manufactured by Eli Lilly, distributed through standard pharmaceutical wholesalers, dispensed by retail and mail-order pharmacies. LillyDirect Pharmacy is Lilly's own direct-to-patient channel using the same brand-name drug (with the single-dose vial as a separate, cheaper SKU).
• Compounded tirzepatide — tirzepatide API sourced from FDA-registered API suppliers, prepared into a multi-dose vial by a state-licensed 503A compounding pharmacy on a patient-specific prescription, dispensed directly to the patient. The clinician consult and the program wrap are provided by the telehealth platform on top of the pharmacy.
• Imported or research-grade peptides — neither legal nor safe. The FDA has issued multiple warnings about the unverified identity, purity, and sterility of tirzepatide products sourced outside the legitimate compounding pathway^[6]. Avoid.

Where NOT to buy tirzepatide

• Anywhere selling tirzepatide without a US prescription
• Any seller shipping from China, India, or Eastern Europe
• Any product labeled "for research use only" or "not for human consumption"
• Any peptide vendor not operating as a state-licensed pharmacy
• Any platform that does not require a real clinician consult
• Any "wellness" or "biohacking" site selling tirzepatide as a supplement

How to actually start

1. Check your insurance. Call the member services number on your insurance card and ask specifically: "Is Zepbound on formulary? What is the prior authorization requirement? What is my copay?" If your plan covers it, this is almost always the cheapest path.
2. If insurance doesn't cover it, decide whether you want brand-name tirzepatide or a compounded preparation. Brand-name via LillyDirect single-dose vials ranges from $299/month (2.5 mg) to $699/month (10-15 mg) as of April 2026, with the Self Pay Journey Program bringing eligible 7.5-15 mg patients to $449/month. Compounded via 503A telehealth is $149-$349/month.
3. Get a clinician consult. See our how to get a GLP-1 prescription guide for the full eligibility framework and the step-by-step path through PCP, telehealth, and obesity medicine specialists.
4. Verify the pharmacy. If you go the compounded route, confirm PCAB accreditation and state board of pharmacy licensure before you pay anything. The telehealth platform should be transparent about which pharmacy fills the prescription.

Related research and tools

• Best tirzepatide providers — full ranked directory of every US telehealth platform offering tirzepatide
• Cheapest tirzepatide providers — sorted by lowest monthly cash price
• GLP-1 Compounded Pricing Index 2026 — live median, p10, p90 pricing across 80+ providers
• Compounded GLP-1 price movement (12 months) — how pricing has shifted post-shortage-resolution
• How to get a GLP-1 prescription in 2026 — eligibility, consult paths, and the four-channel buyer funnel
• GLP-1 insurance coverage: Medicare, Medicaid, commercial — what each plan type actually covers
• PCAB accreditation investigation — how to vet a compounding pharmacy

Frequently asked questions

Is Mounjaro approved for weight loss?

No. Mounjaro is FDA-approved only for type 2 diabetes^[2]. Zepbound is the FDA-approved tirzepatide product for chronic weight management. A clinician can prescribe Mounjaro off-label for weight loss, but most commercial insurers will not cover it without a diabetes diagnosis.

Is compounded tirzepatide still legal in 2026?

Yes, with limits. After the FDA declared the tirzepatide shortage resolved on December 19, 2024^[5], 503B outsourcing facilities wound down bulk-compounding by March 19, 2025 and can no longer mass-compound tirzepatide. 503A pharmacies can still compound tirzepatide for an individual patient when a prescriber documents a clinical need. Most telehealth platforms continue to operate through this 503A pathway.

What is the cheapest legal way to get Zepbound?

For commercially insured patients with Zepbound on formulary, the Lilly savings card combined with insurance coverage is usually the cheapest path. Without insurance, LillyDirect single-dose vials start at $299/month for 2.5 mg and range up to $699/month for 10, 12.5, and 15 mg as of April 2026, following Lilly's December 1, 2025 price reduction^[3][4]. Eligible self-pay patients on 7.5 mg and above may qualify for the Lilly Self Pay Journey Program at $449/month (effective Feb 23, 2026). Compounded tirzepatide via 503A telehealth is typically $149-$349/month.

How much does Zepbound cost at a regular pharmacy?

List price for the Zepbound autoinjector pen at retail pharmacies is roughly $1,000-$1,300/month depending on the dose. The single-dose vial program through LillyDirect is significantly cheaper: $299/month (2.5 mg), $399 (5 mg), $499 (7.5 mg), and $699/month (10, 12.5, 15 mg) as of April 2026, with an additional Self Pay Journey Program discount available to eligible patients on the higher doses.

Does Medicare cover Zepbound?

Medicare Part D historically did not cover weight-loss medications. CMS expanded coverage in March 2024 to allow Wegovy for patients with established cardiovascular disease, but Zepbound coverage under Medicare remains limited as of 2026. Medicaid coverage varies by state.

How do I know if a compounded tirzepatide pharmacy is legitimate?

Look for PCAB accreditation through the Accreditation Commission for Health Care, verify the pharmacy is licensed in your state through your state board of pharmacy, and confirm it operates as a 503A compounding pharmacy with a valid patient-specific prescription^[7]. Avoid any seller offering tirzepatide without a prescription or shipping from outside the US.

Important disclaimer. This article is educational and does not constitute medical advice. Pricing is verified directly from FDA labels, the LillyDirect patient site, and our 80-provider compounded pricing dataset on the publication date. Pricing and availability change frequently — verify directly with the provider before signing up. This is a YMYL article about a real prescription drug; clinical decisions should always involve your prescribing clinician. Weight Loss Rankings has no financial relationship with Eli Lilly or any of the providers referenced.